AlertsNet was funded by the German Ministry of Health (BMG, grant IIA5-2512FSB114) and by the Thuringian Ministry for Social Affairs, Health and Family (TMSFG). Since August 2015 AlertsNet 2.0 is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ 01EO1502, and by the Thuringian Ministry for Social Affairs, Health Care, Family and Women (TMASGFF).
The project is supported by the Paul-Martini-Sepsis Research Group, funded by the Thuringian Ministry of Education, Science and Culture (ProExcellence; grant PE 108-2); the public funded Thuringian Foundation for Technology, Innovation and Research (STIFT) and the German Sepsis Society (GSS); the Jena Center of Sepsis Control and Care (CSCC), funded by the German Ministry of Education and Research (BMBF; grant 01 EO 1002).
The Integrated Research and Treatment Center (IFB) Sepsis and Sepsis Sequences (CSCC) is an institution of the University Hospital Jena and the Faculty of Medicine of the Friedrich-Schiller-University (FSU) of Jena. It is funded as one of a total of eight Integrated Research and Treatment Centers (IFB) in Germany by the Federal Ministry of Education and Research (BMBF).
At the CSCC new structures with interdisciplinary permeability for physicians and scientists are created. The clear separation of tasks in research and in patient care enables new approaches across the entire treatment path of septic patients - from risk assessment to post-hospital long-term care and rehabilitation. The CSCC promotes young scientists and offers numerous opportunities for targeted pre- and post-graduate career development. In order to carry out high quality studies, an efficient center for clinical trials will be expanded and a CSCC biobank established.
The tasks of the BMBF are manifold. On the one hand, the BMBF is largely responsible for legislation in various areas. This primarily includes the field of extracurricular vocational training and further education and the promotion of training. On the other hand, the BMBF financially supports research in all areas of science. In addition, junior researchers and international exchange in education, training or studies are promoted.
The Foundation for Technology, Innovation and Research Thuringia (STIFT) was founded in 1993 under civil law in Erfurt.
STIFT pursues the promotion of science, research and technology in Thuringia. The foundation purpose specified by the founder - the Free State of Thuringia - aims to support the development of the knowledge-based regional, endogenous potentials of the free state.
The purpose of the foundation is realized in particular by:
- - the promotion of science, research and technology in universities, non-university research institutions, research associations, in business-related research institutes and in other institutions,
- - the promotion of the transfer of new scientific knowledge and innovative technologies,
- - the promotion of the transfer of scientific knowledge in favor of the general public in order to support the development of flexible and competitive structures in the technological area of Thuringia,
- - the promotion of start-up behavior and the transfer of scientific knowledge for technology-oriented business start-ups.
STIFT becomes active itself, in which it carries out its own projects, which can also be financed proportionately by third-party funds (such as the EU, the Land). It also contributes to relevant institutions, advisory councils, committees and initiatives. In addition, projects of third parties are also funded within the framework of STIFT.
The non-profit Paul Martini Foundation, Berlin, promotes drug discovery and research on drug therapy and intensifies the scientific dialogue between medical scientists in universities, hospitals, the research-based pharmaceutical industry, other research institutions, and health policy and government officials. The foundation is sponsored by vfa, Berlin, which currently represents 43 research-based pharmaceutical companies.
The foundation is named after the scientist and physician Prof. Paul Martini (1889 - 1964), in recognition of his outstanding contribution to clinical-therapeutic research.
At the Helmholtz Center for Infection Research, scientists are investigating the mechanisms of infectious diseases and their defenses. Results of basic research in the direction of medical application are systematically developed. The scientific questions that are adressed include:
- Why are bacterial or viral species pathogens?
- Why are some people particularly sensitive while others are resistant to infections?
- How can we intervene in infection processes?
- How do we transfer our findings to the human application?
To address such issues, pathogens that are medically relevant or that can be used as a model to study infections are investigated. Understanding these mechanisms will help combat infectious diseases through new drugs and vaccines.
The Free State of Thuringia is a country of the Federal Republic of Germany. With around 2.2 million inhabitants and an area of around 16,000 square kilometers, it is one of the smaller federal states of the Federal Republic. The population density is also slightly below the national average. The state capital and largest city at the same time is Erfurt, while with Jena there is another big city in Thuringia. Neighboring countries are Saxony in the east and southeast, Saxony-Anhalt in the north and northeast, Lower Saxony in the northwest, Hesse in the west and Bavaria in the south. Several places in the northwest of the country claim to be the exact center of Germany.